Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace your aortic valve. The aortic valve controls blood flow from your heart to your aorta, the main artery that ...

A new study shows that patients who underwent a minimally invasive transcatheter aortic-valve replacement (TAVR), had similar key 5-year clinical outcomes of death and stroke as patients who had ...

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability. HealthDay News — Seven-year follow-up data show that transcatheter aortic-valve ...

TOPEKA, Kan. (WIBW) - Stormont Vail Health announced that their cardiology team completed its 500th Transcatheter Aortic Valve Replacement (TAVR) procedure. According to Stormont Vail Health, the TAVR ...

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

TAVR, a minimally invasive alternative to open‑heart surgery for severe aortic stenosis, has become the global standard for elderly and high‑risk patients.

You may not need surgery to repair an aortic valve. A nonsurgical catheter procedure with small incisions may be a better option in some cases. Share on Pinterest Getty Images When the aortic valve in ...

Robert Shanahan needed surgery only twice in his life coming into this year, once to remove his tonsils when he was young, the other more recently when he needed a stent to open one of his blood ...

MINSK, 10 January (BelTA) – Doctors of the Interventional Radiology Suite of the National Teaching Medical Center have performed a minimally invasive aortic valve replacement surgery on a 78-year-old ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

Transcatheter aortic valve replacement for inoperable severe, symptomatic aortic stenosis will create significant social value in the next decade, mostly accruing to patients versus manufacturers.